Ernexa Therapeutics Inc. ERNA
3.45
(0.17)
(4.70%)
as of 25 Sep
- Market cap
- $5.9M
- P/E
- 0.0×
Follow ERNA
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
— | — | — | — |
EV/Sales |
— | — | — | — | |
EV/FCF |
— | — | — | — | |
Quick Ratio |
1.49 | 0.64 | 2.65 | 1.74 | |
Current Ratio |
1.58 | 1.01 | 2.89 | 2.01 | |
Net Debt/EBITDA |
1.58 | 0.93 | 2.65 | 1.24 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
1.03 | 0.76 | 0.41 | 1.03 | |
Capex/Depreciation |
(0.31) | (0.22) | 0.00 | (0.07) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.33 | 0.35 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow Yield |
— | — | — | — | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(3.87) | (4.55) | (2.86) | (3.51) | |
Capex per Share |
(0.07) | (0.06) | 0.00 | 0.00 | |
Free Cash Flow per Share |
(3.93) | (4.61) | (2.86) | (3.51) | |
Cash per Share |
9.26 | 7.47 | 11.59 | 4.25 | |
Shareholders Equity per Share |
10.85 | 9.52 | 8.66 | 2.71 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
10.85 | 9.52 | 8.66 | 2.71 | |
Free Cash Flow |
(1.29) | (1.16) | (2.27) | (4.15) | |
Working Capital |
1.24 | 0.02 | 6.54 | 2.96 | |
Capital Expenditures |
(0.02) | (0.01) | 0.00 | 0.00 | |
Net Current Asset Value |
0.78 | (0.30) | 6.31 | 2.78 | |
EV/EBIT |
— | — | — | — | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% | |
| Other line items | |||||
Average Receivables |
0.17 | 0.27 | — | 0.12 | |
Average Payables |
1.58 | 1.42 | 1.29 | 1.35 | |
Average Assets |
6.95 | 5.55 | 7.80 | 6.95 | |
Average Common Equity |
(20.91) | 2.05 | 0.45 | 3.82 |
Columns are period end dates